Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-08-04

Clinical Trial Results: Aquacel Hypersensitivity Dressing in TJAs [Phase 4]

View source ↗

Summary

Phase 4 trial results for Aquacel Hypersensitivity Dressing in total joint arthroplasty evaluating contact allergic dermatitis and adverse skin reactions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aquacel Hypersensitivity Dressing

Snippet

Sponsor: Rush University Medical Center | Conditions: Contact Allergic Dermatitis, Adverse Skin Reaction | Phase 4 | Status: COMPLETED | Results posted: 2026-08-04